Disorders with PML associated with activity disorders are a dubious disease in the field of the nervous system, clinical performance is complex and often involves multi-system congestion. Early identification and normalisation of clinical care are essential for improving prognosis. The diagnosis of the disease requires a combination of clinical performance, imaging inspection, laboratory testing and pathological activation.
The platform can assist in matching the needs of a team of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. Individualised development of treatment programs for treatment and management of PML associated with activity disorders, usually including drug therapy, rehabilitation interventions, and regular follow-up to multiple management. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many neurological diseases that have been difficult to treat have been significantly improved.
Treatment needs to be closely monitored for effectiveness and adverse reactions, adapted to the timely schedule according to the changes in the disease. Multidisciplinary collaboration (MDT) is particularly important for the integrated management of PML-associated reactive disorders. 2.
Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.